• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 PELVICOL® ACELLULAR COLLAGEN MATRIX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 PELVICOL® ACELLULAR COLLAGEN MATRIX Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
No sample received.
 
Event Description
The patient's attorney alleged a deficiency against the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELVICOL® ACELLULAR COLLAGEN MATRIX
Type of Device
PELVICOL® ACELLULAR COLLAGEN MATRIX
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key12882210
MDR Text Key281325448
Report Number1018233-2021-80096
Device Sequence Number1
Product Code PAG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Event Location Hospital
Initial Date Manufacturer Received 11/19/2021
Initial Date FDA Received11/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALIGN® TO URETHRAL SUPPORT SYSTEM - HALO; AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM; AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR; PELVISOFT® ACELLULAR COLLAGEN BIOMESH
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexFemale
Patient Weight82 KG
-
-